75 related articles for article (PubMed ID: 25418033)
1. A caged substrate peptide for matrix metalloproteinases.
Decaneto E; Abbruzzetti S; Heise I; Lubitz W; Viappiani C; Knipp M
Photochem Photobiol Sci; 2015 Feb; 14(2):300-7. PubMed ID: 25418033
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.
Neumann U; Kubota H; Frei K; Ganu V; Leppert D
Anal Biochem; 2004 May; 328(2):166-73. PubMed ID: 15113693
[TBL] [Abstract][Full Text] [Related]
3. Monitoring metalloproteinase activity using synthetic fluorogenic substrates.
Troeberg L; Nagase H
Curr Protoc Protein Sci; 2004 Nov; Chapter 21():21.16.1-21.16.9. PubMed ID: 18429258
[TBL] [Abstract][Full Text] [Related]
4. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Knight CG; Willenbrock F; Murphy G
FEBS Lett; 1992 Jan; 296(3):263-6. PubMed ID: 1537400
[TBL] [Abstract][Full Text] [Related]
5. Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.
Lauer-Fields JL; Kele P; Sui G; Nagase H; Leblanc RM; Fields GB
Anal Biochem; 2003 Oct; 321(1):105-15. PubMed ID: 12963061
[TBL] [Abstract][Full Text] [Related]
6. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
Hurst DR; Schwartz MA; Ghaffari MA; Jin Y; Tschesche H; Fields GB; Sang QX
Biochem J; 2004 Feb; 377(Pt 3):775-9. PubMed ID: 14533979
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cleavage of diaminopimelate-containing isopeptides by leucine aminopeptidase and matrix metalloproteinases in tumors: application to bioadhesive peptides.
Yamazaki Y; Savva M; Kleinman HK; Oka S; Mokotoff M
J Pept Res; 1999 Feb; 53(2):177-87. PubMed ID: 10195455
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
Kolkenbrock H; Essers L; Ulbrich N; Will H
Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
[TBL] [Abstract][Full Text] [Related]
10. Expression in Escherichia coli, refolding, and purification of the recombinant mature form of human matrix metalloproteinase 7 (MMP-7).
Muta Y; Yasui N; Matsumiya Y; Kubo M; Inouye K
Biosci Biotechnol Biochem; 2010; 74(12):2515-7. PubMed ID: 21150109
[TBL] [Abstract][Full Text] [Related]
11. The synthesis and application of Fmoc-Lys(5-Fam) building blocks.
Tokmina-Roszyk M; Tokmina-Roszyk D; Fields GB
Biopolymers; 2013 Jul; 100(4):347-55. PubMed ID: 23444261
[TBL] [Abstract][Full Text] [Related]
12. Substrate specificity of cucumisin on synthetic peptides.
Yonezawa H; Kaizuka H; Uchikoba T; Arima K; Kaneda M
Biosci Biotechnol Biochem; 2000 Oct; 64(10):2104-8. PubMed ID: 11129582
[TBL] [Abstract][Full Text] [Related]
13. A possibility of a protein-bound water molecule as the ionizable group responsible for pKe at the alkaline side in human matrix metalloproteinase 7 activity.
Morishima A; Yasukawa K; Inouye K
J Biochem; 2012 May; 151(5):501-9. PubMed ID: 22368250
[TBL] [Abstract][Full Text] [Related]
14. Triple-helical peptide analysis of collagenolytic protease activity.
Lauer-Fields JL; Fields GB
Biol Chem; 2002; 383(7-8):1095-105. PubMed ID: 12437092
[TBL] [Abstract][Full Text] [Related]
15. A caged sperm-activating peptide that has a photocleavable protecting group on the backbone amide.
Tatsu Y; Nishigaki T; Darszon A; Yumoto N
FEBS Lett; 2002 Aug; 525(1-3):20-4. PubMed ID: 12163154
[TBL] [Abstract][Full Text] [Related]
16. Interaction of 8-anilinonaphthalene 1-sulphonate (ANS) and human matrix metalloproteinase 7 (MMP-7) as examined by MMP-7 activity and ANS fluorescence.
Samukange V; Yasukawa K; Inouye K
J Biochem; 2012 May; 151(5):533-40. PubMed ID: 22390874
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamic analysis of ionizable groups involved in the catalytic mechanism of human matrix metalloproteinase 7 (MMP-7).
Takeharu H; Yasukawa K; Inouye K
Biochim Biophys Acta; 2011 Dec; 1814(12):1940-6. PubMed ID: 21787888
[TBL] [Abstract][Full Text] [Related]
18. Effects of heparin and cholesterol sulfate on the activity and stability of human matrix metalloproteinase 7.
Samukange V; Yasukawa K; Inouye K
Biosci Biotechnol Biochem; 2014; 78(1):41-8. PubMed ID: 25036482
[TBL] [Abstract][Full Text] [Related]
19. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
20. Degradation of tropoelastin by matrix metalloproteinases--cleavage site specificities and release of matrikines.
Heinz A; Jung MC; Duca L; Sippl W; Taddese S; Ihling C; Rusciani A; Jahreis G; Weiss AS; Neubert RH; Schmelzer CE
FEBS J; 2010 Apr; 277(8):1939-56. PubMed ID: 20345904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
